Genetic changes in squamous cell lung cancer: a review, J Thorac Oncol, vol.7, pp.924-933, 2012. ,
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype, EMBO Mol Med, vol.6, pp.539-550, 2014. ,
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer, J Clin Oncol, vol.22, pp.2184-2191, 2004. ,
Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer, Oncologist, vol.15, pp.436-446, 2010. ,
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc Natl Acad Sci U S A, vol.90, pp.10705-10709, 1993. ,